Abstract
Abstract 5629: Arginine depravation therapy with arginine deiminase and autophagy inhibition is a novel therapeutic approach for the treatment of metastatic sarcomas that lack argininosuccinate synthetase expression
Cancer research (Chicago, Ill.), Vol.72(8 Supplement), pp.5629-5629
04/15/2012
DOI: 10.1158/1538-7445.AM2012-5629
Abstract
Proceedings: AACR 103rd Annual Meeting 2012‐‐ Mar 31‐Apr 4, 2012; Chicago, IL
conference abstract
Details
- Title: Subtitle
- Abstract 5629: Arginine depravation therapy with arginine deiminase and autophagy inhibition is a novel therapeutic approach for the treatment of metastatic sarcomas that lack argininosuccinate synthetase expression
- Creators
- Dean Weich - Washington University in St. LouisShunqiang Li - Washington University in St. LouisTom Kitchens - Washington University in St. LouisMunir R Tanas - Cleveland ClinicPhilip Boone - Washington University in St. LouisDavid Y Chen - Washington University in St. LouisDouglas R Adkins - Washington University in St. LouisJohn Bomalski - Polaris IndustriesBrian P Rubin - Cleveland ClinicBrian A Van Tine - Washington University in St. Louis
- Resource Type
- Abstract
- Publication Details
- Cancer research (Chicago, Ill.), Vol.72(8 Supplement), pp.5629-5629
- DOI
- 10.1158/1538-7445.AM2012-5629
- ISSN
- 0008-5472
- eISSN
- 1538-7445
- Language
- English
- Date published
- 04/15/2012
- Academic Unit
- Pathology
- Record Identifier
- 9984201423002771
Metrics
1 Record Views